Michelle has been part of the Bonebridge team almost since our inception. She has played a pivotal role in Bonebridge's development from an early-stage company to the growing international organization we are today.
“Michelle has successfully guided our quality and regulatory functions through periods of significant growth and into different markets, built a strong team, and consistently demonstrated outstanding leadership qualities,” says Dr. Christof Gerber, Bonebridge CEO. “This appointment is both a recognition of her contribution to date and an expression of our confidence in the role she will play in shaping Bonebridge's future.”
Michelle originally joined Bonebridge in 2020. She holds a Master of Science degree in biotechnology from the University of Natural Resources and Life Sciences (BOKU) in Vienna and completed her master's thesis at the Centre national de la recherche scientifique (CNRS) Toulouse, France. She is also currently pursuing an International Executive MBA at the University of St. Gallen (HSG).
“I am honored by this opportunity and the trust placed in me. Bonebridge has been an incredible journey over the past few years,” Michelle says about her appointment. “I look forward to working with our exceptional team to continue building the company and expanding our impact globally.”
Congratulations, Michelle, on this well-deserved appointment – we look forward to continue working with you in your new role!